MCID: PRV003
MIFTS: 42

Perivascular Epithelioid Cell Tumor

Categories: Cancer diseases

Aliases & Classifications for Perivascular Epithelioid Cell Tumor

MalaCards integrated aliases for Perivascular Epithelioid Cell Tumor:

Name: Perivascular Epithelioid Cell Tumor 12 14
Perivascular Epithelioid Cell Neoplasms 41 69
Neoplasm with Perivascular Epithelioid Cell Differentiation 12
Pecoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2643
MeSH 41 D054973
NCIt 46 C38150
SNOMED-CT 64 388601000
UMLS 69 C1300127

Summaries for Perivascular Epithelioid Cell Tumor

MalaCards based summary : Perivascular Epithelioid Cell Tumor, also known as perivascular epithelioid cell neoplasms, is related to lymphangioleiomyomatosis and tuberous sclerosis. An important gene associated with Perivascular Epithelioid Cell Tumor is TSC2 (TSC Complex Subunit 2), and among its related pathways/superpathways are Cytoskeletal Signaling and Aurora B signaling. The drugs Everolimus and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include liver, uterus and lung, and related phenotypes are cardiovascular system and muscle

Related Diseases for Perivascular Epithelioid Cell Tumor

Diseases related to Perivascular Epithelioid Cell Tumor via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 248)
# Related Disease Score Top Affiliating Genes
1 lymphangioleiomyomatosis 30.1 DES PGR TSC2
2 tuberous sclerosis 30.0 SYP TSC2 VIM
3 angiosarcoma 30.0 KIT MUC1 VIM
4 alveolar soft part sarcoma 29.9 DES SYP VIM
5 pneumothorax 29.8 MUC1 PGR VIM
6 angiomyolipoma 29.2 ACTC1 DES KIT PGR TSC2
7 gastrointestinal stromal tumor 29.2 ACTC1 DES KIT SYP VIM
8 leiomyoma 28.9 ACTC1 DES MME PGR
9 smooth muscle tumor 28.0 ACTC1 DES KIT MME PGR VIM
10 uterus perivascular epithelioid cell tumor 12.3
11 lymphangiectasis 10.5 ACTC1 VIM
12 glomangiomyoma 10.5 ACTC1 VIM
13 intravascular papillary endothelial hyperplasia 10.5 ACTC1 VIM
14 hepatitis 10.5
15 malignant peritoneal mesothelioma 10.4 MUC1 VIM
16 fibroblastic rheumatism 10.4 ACTC1 DES
17 fibrous meningioma 10.4 MUC1 VIM
18 nodular hidradenoma 10.4 MUC1 VIM
19 eccrine porocarcinoma 10.4 MUC1 VIM
20 myxopapillary ependymoma 10.4 MUC1 VIM
21 spindle cell thymoma 10.4 DES MUC1
22 monophasic synovial sarcoma 10.4 MUC1 VIM
23 sarcomatoid mesothelioma 10.4 MUC1 VIM
24 spindle cell rhabdomyosarcoma 10.4 DES MUC1
25 skin glomus tumor 10.4 DES VIM
26 myxofibrosarcoma 10.4 DES MUC1
27 infantile digital fibromatosis 10.4 DES VIM
28 hidradenoma 10.4 MUC1 VIM
29 primitive neuroectodermal tumor of the cervix uteri 10.4 DES VIM
30 mucinous cystadenocarcinoma 10.4 MUC1 VIM
31 chondroid chordoma 10.4 MUC1 VIM
32 dedifferentiated liposarcoma 10.4 ACTC1 DES
33 plasmablastic lymphoma 10.4 DES MUC1
34 proximal spinal muscular atrophy 10.4 DES MUC1
35 non-langerhans-cell histiocytosis 10.4 ACTC1 DES
36 juvenile xanthogranuloma 10.4 DES VIM
37 reticular perineurioma 10.3 KIT MUC1
38 sinonasal undifferentiated carcinoma 10.3 MUC1 SYP
39 middle ear adenoma 10.3 MUC1 SYP
40 granular cell tumor 10.3 DES VIM
41 aggressive digital papillary adenocarcinoma 10.3 KIT MUC1
42 ovarian small cell carcinoma 10.3 MUC1 SYP
43 mast-cell sarcoma 10.3 KIT VIM
44 sarcomatoid renal cell carcinoma 10.3 KIT MUC1
45 primary hepatic neuroendocrine carcinoma 10.3 SYP VIM
46 rhabdoid meningioma 10.3 SYP VIM
47 large cell medulloblastoma 10.3 SYP VIM
48 polycystic liver disease 1 10.3 ACTC1 MUC1
49 mucinous ovarian cystadenoma 10.3 MUC1 SYP
50 gallbladder sarcoma 10.3 DES KIT

Graphical network of the top 20 diseases related to Perivascular Epithelioid Cell Tumor:



Diseases related to Perivascular Epithelioid Cell Tumor

Symptoms & Phenotypes for Perivascular Epithelioid Cell Tumor

MGI Mouse Phenotypes related to Perivascular Epithelioid Cell Tumor:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.43 ACTC1 DES KIT PGR TSC2 VIM
2 muscle MP:0005369 9.02 ACTC1 DES KIT PGR VIM

Drugs & Therapeutics for Perivascular Epithelioid Cell Tumor

Drugs for Perivascular Epithelioid Cell Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 80)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
2
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
3
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 46835353 6436030 5284616
4
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
5 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1
6 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1
7 Antifungal Agents Phase 4,Phase 3,Phase 2,Phase 1
8 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
9 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1
10 Antimalarials Phase 4,Phase 1
11 Antiparasitic Agents Phase 4,Phase 1
12 Antiprotozoal Agents Phase 4,Phase 1
13
Doxorubicin Approved, Investigational Phase 3,Phase 2 23214-92-8 31703
14
Trabectedin Approved, Investigational Phase 3 114899-77-3 108150
15
Cyclophosphamide Approved, Investigational Phase 2, Phase 3 50-18-0, 6055-19-2 2907
16
Ifosfamide Approved Phase 2, Phase 3 3778-73-2 3690
17
Mechlorethamine Approved, Investigational Phase 2, Phase 3 51-75-2 4033
18
Doxil Approved June 1999 Phase 3,Phase 2 31703
19 Alkylating Agents Phase 3,Phase 2
20 Isophosphamide mustard Phase 2, Phase 3 0
21 Topoisomerase Inhibitors Phase 2, Phase 3
22
Propranolol Approved, Investigational Phase 2 525-66-6 4946
23
Letrozole Approved, Investigational Phase 2 112809-51-5 3902
24
Octreotide Approved, Investigational Phase 2 83150-76-9 6400441 383414
25
Somatostatin Approved, Investigational Phase 2 38916-34-6, 51110-01-1 53481605
26
Menthol Approved Phase 2 2216-51-5 16666
27
Nintedanib Approved Phase 2 656247-17-5 56843413
28
Celecoxib Approved, Investigational Phase 2 169590-42-5 2662
29
Simvastatin Approved Phase 1, Phase 2 79902-63-9 54454
30
Resveratrol Approved, Experimental, Investigational Phase 2 501-36-0 445154
31
Saracatinib Investigational Phase 2,Phase 1 379231-04-6
32 Adrenergic Agents Phase 2
33 Adrenergic Antagonists Phase 2
34 Adrenergic beta-Antagonists Phase 2
35 Angiogenesis Inhibitors Phase 2
36 Anti-Arrhythmia Agents Phase 2
37 Antihypertensive Agents Phase 2
38 Neurotransmitter Agents Phase 2
39 Vasodilator Agents Phase 2
40 Aromatase Inhibitors Phase 2
41 Estrogen Antagonists Phase 2
42 Estrogens Phase 2
43 Hormone Antagonists Phase 2
44 Hormones Phase 2
45 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2
46 Steroid Synthesis Inhibitors Phase 2
47 Antineoplastic Agents, Hormonal Phase 2
48 Gastrointestinal Agents Phase 2
49 Antirheumatic Agents Phase 2,Phase 1
50 Imatinib Mesylate Phase 1, Phase 2 123596

Interventional clinical trials:

(show all 45)

# Name Status NCT ID Phase Drugs
1 Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis Completed NCT01217125 Phase 4 Sirolimus
2 Doxycycline In Lymphangioleiomyomatosis (LAM) Completed NCT00989742 Phase 4 Doxycycline;Placebo
3 Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM) Unknown status NCT00414648 Phase 3 Sirolimus;Placebo sirolimus
4 Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) Completed NCT00790400 Phase 3 Everolimus (RAD001);Everolimus Placebo
5 Trabectedin Maintenance Post 1st-line in STS Recruiting NCT02929394 Phase 3 Trabectedin
6 Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Recruiting NCT02180867 Phase 2, Phase 3 Doxorubicin Hydrochloride;Ifosfamide;Pazopanib Hydrochloride
7 Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial Not yet recruiting NCT03150914 Phase 3 Sirolimus
8 Sirolimus in Treating Patients With Angiomyolipoma of the Kidney Unknown status NCT00126672 Phase 2 sirolimus
9 Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM Unknown status NCT00490789 Phase 2 sirolimus
10 Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers Completed NCT02104011 Phase 2 Propranolol
11 Trial of Aromatase Inhibition in Lymphangioleiomyomatosis Completed NCT01353209 Phase 2 Letrozole;Placebo
12 A Study to Determine the Effectiveness of Escalating Doses of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis Completed NCT01059318 Phase 2 Everolimus;Everolimus;Everolimus
13 Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM) Completed NCT00792766 Phase 1, Phase 2 everolimus (RAD001)
14 RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM Completed NCT00457964 Phase 1, Phase 2 RAD001
15 Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM Completed NCT00457808 Phase 2 Rapamycin, sirolimus
16 Treatment With Octreotide in Patients With Lymphangioleiomyomatosis Completed NCT00005906 Phase 2 Octreotide
17 A Phase 2 Study of ABI-009 in Patients With Advanced Malignant PEComa Recruiting NCT02494570 Phase 2 ABI-009
18 Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus Recruiting NCT02539459 Phase 2 Everolimus
19 LAM Pilot Study With Imatinib Mesylate Recruiting NCT03131999 Phase 1, Phase 2 Imatinib Mesylate 400Mg Capsule;Placebo - Capsule
20 A Study of Nintedanib for LymphAngioleioMyomatosis (LAM) Recruiting NCT03062943 Phase 2 Nintedanib
21 Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis Recruiting NCT02737202 Phase 2 saracatinib
22 COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC Recruiting NCT02484664 Phase 2 Celecoxib
23 Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis Recruiting NCT01799538 Phase 2 albuterol inhaler;albuterol nebulizer
24 Safety of Simvastatin in LAM and TSC Recruiting NCT02061397 Phase 1, Phase 2 Simvastatin
25 Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial Not yet recruiting NCT03253913 Phase 2 Sirolimus;Resveratrol
26 A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa Withdrawn NCT01690871 Phase 2 BEZ235
27 The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1) Completed NCT02116712 Phase 1 Saracatinib
28 Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis Completed NCT01687179 Phase 1 sirolimus and hydroxychloroquine
29 Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors Completed NCT02334930
30 Pulmonary Rehabilitation in Lymphangioleiomyomatosis Completed NCT02009241
31 Pulmonary Hypertension in Lymphangioleiomyomatosis Completed NCT00960895
32 Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women Completed NCT00552955
33 Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases Completed NCT00366509
34 Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM) Completed NCT00001869
35 Lymphangioleiomyomatosis (LAM) Registry Completed NCT00005486
36 Discovery of Sirolimus Sensitive Biomarkers in Blood Recruiting NCT03304678
37 A National Registry on Chinese Patients With Lymphangioleiomyomatosis Recruiting NCT03193892
38 Safety and Durability of Sirolimus for Treatment of LAM Recruiting NCT02432560 Sirolimus;Everolimus
39 Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France Recruiting NCT02887781
40 The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients Recruiting NCT02859194
41 Lymphatic Anomalies Registry Recruiting NCT02399527
42 Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma Recruiting NCT02325505
43 National Lymphangioleiomyomatosis Registry, France Recruiting NCT01484236
44 Study of the Disease Process of Lymphangioleiomyomatosis Recruiting NCT00001465
45 EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications Not yet recruiting NCT03477149 Not Applicable

Search NIH Clinical Center for Perivascular Epithelioid Cell Tumor

Cochrane evidence based reviews: perivascular epithelioid cell neoplasms

Genetic Tests for Perivascular Epithelioid Cell Tumor

Anatomical Context for Perivascular Epithelioid Cell Tumor

MalaCards organs/tissues related to Perivascular Epithelioid Cell Tumor:

38
Liver, Uterus, Lung, Kidney, Colon, Cervix, Pancreas

Publications for Perivascular Epithelioid Cell Tumor

Articles related to Perivascular Epithelioid Cell Tumor:

(show top 50) (show all 190)
# Title Authors Year
1
Recurrence of retroperitoneal localized perivascular epithelioid cell tumor two years after initial diagnosis: case report. ( 29340502 )
2018
2
Hepatic perivascular epithelioid cell tumor treated by transarterial embolization plus radiofrequency ablation: A case report and literature review. ( 28562547 )
2017
3
Liver Perivascular Epithelioid Cell Tumor with an Unusual Location: Diagnostic Characteristics with Multidetector Computed Tomography and Magnetic Resonance Imaging. ( 28975043 )
2017
4
Pneumothorax caused by cystic and nodular lung metastases from a malignant uterine perivascular epithelioid cell tumor (PEComa). ( 28706850 )
2017
5
Case of lymph node primary perivascular epithelioid cell tumor associated with leukoderma. ( 28868802 )
2017
6
An orbital perivascular epithelioid cell tumor in a 7-year-old boy: case report and review of the literature. ( 28576480 )
2017
7
Perivascular Epithelioid Cell Tumor (PEComa) of the Uterine Cervix: A Case Report of a 43-Yr-Old Woman With Abnormal Uterine Bleeding Treated With Hysterectomy. ( 28787320 )
2017
8
Perirenal perivascular epithelioid cell tumor (PEComa) coexisting with other malignancies: a case report. ( 28547987 )
2017
9
Malignant perivascular epithelioid cell tumor of the orbit: Report of a case and review of literature. ( 28905842 )
2017
10
Computed tomography imaging features of hepatic perivascular epithelioid cell tumor: A case report and literature review. ( 29245304 )
2017
11
Hepatic perivascular epithelioid cell tumor (PEComa): a case report with a review of literatures. ( 28288506 )
2017
12
Perivascular Epithelioid Cell Tumor in the Stomach. ( 28372349 )
2017
13
Cardiac Perivascular Epithelioid Cell Tumor. ( 28415905 )
2017
14
Primary cutaneous perivascular epithelioid cell tumor (PEComa): Five new cases and review of the literature. ( 28556973 )
2017
15
Malignant perivascular epithelioid cell tumor of the oropharynx with strong TFE3 expression mimicking alveolar soft part sarcoma: a case report and review of the literature. ( 29208563 )
2017
16
Two cases of perivascular epithelioid cell tumor of the uterus: clinical, radiological and pathological diagnostic challenge. ( 28270196 )
2017
17
A systematic review: perivascular epithelioid cell tumor of gastrointestinal tract. ( 27428182 )
2016
18
Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the Literature. ( 27793946 )
2016
19
Perivascular epithelioid cell tumor of the uterus: Report of two cases and mini-review of the literature. ( 27689526 )
2016
20
Broad Ligament Perivascular Epithelioid Cell Tumor (PEComa) of Uncertain Malignant Potential. ( 26832182 )
2016
21
Pigmented perivascular epithelioid cell tumor (PEComa) arising from kidney: A case report. ( 27858882 )
2016
22
Hepatic perivascular epithelioid cell tumor: Case report and brief literature review. ( 28002331 )
2016
23
Intrahepatic peribiliary perivascular epithelioid cell tumor (PEComa) associated with heterotopic pancreas: A case report. ( 27542598 )
2016
24
Perivascular Epithelioid Cell Tumor of the Uterus with Ovarian Involvement: A Case Report and Review of the Literature. ( 27150246 )
2016
25
Sclerosing Perivascular Epithelioid Cell Tumor of the Lung: A Case Report with Cytologic Findings. ( 27068025 )
2016
26
Cutaneous Perivascular Epithelioid Cell Tumor of Gynecologic Origin Metastatic to Skin, Lung, Stomach, and Brain. ( 27149334 )
2016
27
Long-lasting stable disease with mTOR inhibitor treatment in a patient with a perivascular epithelioid cell tumor: A case report and literature review. ( 28105182 )
2016
28
Perivascular epithelioid cell tumor of the descending colon mimicking a gastrointestinal stromal tumor: a case report. ( 27842558 )
2016
29
Hepatic perivascular epithelioid cell tumor in three patients. ( 27919857 )
2016
30
Perivascular Epithelioid Cell Tumor (PEComa) of Pancreas Diagnosed Preoperatively by Endoscopic Ultrasound-Guided Fine-Needle Aspiration: A Case Report and Review of Literature. ( 27628738 )
2016
31
Pancreatic perivascular epithelioid cell tumor: A case report with clinicopathological features and a literature review. ( 27053862 )
2016
32
Primary Perivascular Epithelioid Cell Tumor (PEComa) of the Bladder: A Case Report With 2-Years of Follow-Up and Review of Current Literature. ( 27793610 )
2016
33
Perivascular epithelioid cell tumor of the ileum. A case report. ( 26900883 )
2016
34
Hepatic perivascular epithelioid cell tumor: five case reports and literature review. ( 25554668 )
2015
35
Perivascular epithelioid cell tumor of the uterine cervix identified on a conventional cervical smear. ( 26390283 )
2015
36
HMB-45 negative multifocal malignant perivascular epithelioid cell tumor of the soft tissue responding to sirolimus: First case report from India. ( 26881640 )
2015
37
Pigmented Perivascular Epithelioid Cell Tumor of the Skin: First Case Report. ( 26355762 )
2015
38
Perivascular Epithelioid Cell Tumor Masquerading as Retained Placenta. ( 26206840 )
2015
39
Ruptured pericardial perivascular epithelioid cell tumor (PEComa) leading to sudden death: an autopsy case report and review of the literature. ( 26386746 )
2015
40
Perivascular epithelioid cell tumor in the duodenum: challenge in differential diagnosis. ( 26339433 )
2015
41
Coincidence between malignant perivascular epithelioid cell tumor arising in the gastric serosa and lung adenocarcinoma. ( 25632212 )
2015
42
Perivascular Epithelioid Cell Tumor of the Liver. ( 26350655 )
2015
43
A recurrent perivascular epithelioid cell tumor of sigmoid colon with pancreatic metastasis: an extremely rare case report and review of the literature. ( 26567117 )
2015
44
Malignant hepatic perivascular epithelioid cell tumor (PEComa) - Case report and a brief review. ( 26071321 )
2015
45
Malignant perivascular epithelioid cell tumor (PEComa) of the femur: a case report and literature review. ( 26022435 )
2015
46
Improving recognition of hepatic perivascular epithelioid cell tumor: Case report and literature review. ( 25954119 )
2015
47
Perivascular epithelioid cell tumor of gastrointestinal tract: case report and review of the literature. ( 25621681 )
2015
48
PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity. ( 26274027 )
2015
49
Malignant perivascular epithelioid cell tumor arising in the mesentery: A case report. ( 26137038 )
2015
50
Perivascular Epithelioid Cell Tumor of the Liver. ( 26601751 )
2015

Variations for Perivascular Epithelioid Cell Tumor

Expression for Perivascular Epithelioid Cell Tumor

Search GEO for disease gene expression data for Perivascular Epithelioid Cell Tumor.

Pathways for Perivascular Epithelioid Cell Tumor

Pathways related to Perivascular Epithelioid Cell Tumor according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.75 ACTC1 DES MUC1 VIM
2
Show member pathways
10.81 DES VIM
3 10.66 ACTC1 DES VIM

GO Terms for Perivascular Epithelioid Cell Tumor

Cellular components related to Perivascular Epithelioid Cell Tumor according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 neuron projection terminus GO:0044306 8.62 MME SYP

Biological processes related to Perivascular Epithelioid Cell Tumor according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 intermediate filament organization GO:0045109 8.96 DES VIM
2 muscle filament sliding GO:0030049 8.8 ACTC1 DES VIM

Sources for Perivascular Epithelioid Cell Tumor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....